Indegene

Indegene Limited is a company offering research and development and management services to healthcare and pharmaceutical enterprises.[4][5][6] It was founded in 1998 and is based in Bangalore, India.[3]

Indegene Limited
TypePrivate
IndustryHealth information technology
Founded1998 (1998)
FoundersRajesh Nair
Manish Gupta
Sanjay Parikh
Anand Kiran
Gaurav Kapoor
Headquarters
Bangalore
,
India
Area served
Worldwide
Key people
Manish Gupta (CEO)[1]
RevenueIncrease ₹1,665 crore (US$210 million) (FY22)[2]
Increase ₹163 crore (US$20 million) (FY22)[2]
Number of employees
4,100 (2021)[3]
Websitewww.indegene.com

History

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.[7] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.[8] In 2008, Medsn officially became known as Indegene Pharmaceutical Solutions in the United States.[9] In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States.[6][10]

In 2009, Indegene signed a master service agreement with six pharmaceutical companies.[5][11] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million.[12] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014.[13]

In February 2021, Carlyle and Brighton Park invested $200 million in Indegene.[14]

Operations

Indegene has offices in India, the United States, the European Union, and Asia-Pacific.[15][10]

In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.[16]

See also

References
  1. "Indegene on the prowl for global acquisitions". The Hindu Businessline. 12 August 2020. Retrieved 8 January 2023.
  2. "Indegene files papers with Sebi; eyes ₹3,200 crore via IPO". mint. 15 December 2022. Retrieved 8 January 2023.
  3. Murayama, Keiichi (19 February 2015). "India's tech muscle has the world's attention". The Nikkei. Retrieved 2 October 2015.
  4. Das, Avik (2 September 2015). "Flipkart, Practo CEOs get top rating from staff". The Economic Times. Retrieved 2 October 2015.
  5. Singh, Seema (7 May 2009). "Cutting pharma costs by intelligent marketing". Mint. Retrieved 2 October 2015.
  6. Unnikrishnan, CH (8 November 2006). "Indegene buys US firm". Business Standard. Retrieved 2 October 2015.
  7. Amirapu, Deepika (9 March 2012). "Indegene eyes US call centre buy for $10–15 million". The Economic Times. Retrieved 2 October 2015.
  8. D'Silva, Jeetha (17 September 2005). "Indegene acquires US medical education co". The Economic Times. Retrieved 2 October 2015.
  9. "Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model". PR Newswire. 14 May 2008. Retrieved 2 October 2015.
  10. "Indegene acquires MedCases, LLC". NFV Zone. 30 November 2006. Retrieved 2 October 2015.
  11. "Indegene highlights benefits of patient adherence programs for pharma cos". PharmaBiz. 3 June 2011. Retrieved 2 October 2015.
  12. Mukherjee, Rupali (7 November 2012). "Indegene to acquire Canada-based company for $4 million". Times of India. Retrieved 2 October 2015.
  13. Craig, Tara (9 January 2014). "Indegene acquires Total Therapeutic Management". PMLive.com. Retrieved 2 October 2015.
  14. Madhurima, Nandy (3 February 2021). "Indegene to raise $200 mn from Carlyle, Brighton Park". LiveMint. Retrieved 20 August 2021.
  15. Vijay, Nandita (7 November 2012). "Indegene plans next phase of growth through acquisition in US, EU markets". PharmaBiz. Retrieved 2 October 2015.
  16. "Best companies to work for 2012: Companies that came up trumps across various sectors". The Economic Times. 16 July 2012. Retrieved 2 October 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.